FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Evaric Pharmaceuticals Lisinopril Tablets Recall

Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart,…

Evaric Pharmaceuticals Inc. · Hauppauge, NY

Risk level
Class II
Reported by FDA
Nov 27, 2024
Recall ID
D-0061-2025
Check your lot numberHow we source this data

Summary

Evaric Pharmaceuticals recalled Lisinopril Tablets starting Nov 15, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0061-2025 on Nov 27, 2024. Reason: Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

Product description

Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.

Lot numbers, UPCs & expiration codes

Lot #: 241103, exp. date 05/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0061-2025
Classification
Class II
Status
Terminated
Recall initiated
Nov 15, 2024
FDA report date
Nov 27, 2024
Quantity
222, 600 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Evaric Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0061-2025, exactly as published.

Show all FDA fields
City
Hauppauge
State
NY
Status
Terminated
Country
United States
Event ID
95749
Address
155 Commerce Dr
Code information
Lot #: 241103, exp. date 05/31/2026
Postal code
11788-3925
Report date
Nov 27, 2024
Product type
Drugs
Recall number
D-0061-2025
Classification
Class II
Recalling firm
Evaric Pharmaceuticals Inc.
Product quantity
222, 600 bottles
Termination date
Apr 23, 2026
Reason for recall
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 15, 2024
Initial firm notification
Letter
Center classification date
Nov 20, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0061-2025, published Nov 27, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls